Searched for
CHINA PHARMA LAWS
Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...- India's Pharma 2.0: How policy and entrepreneurs built the pharmacy of the worldIndia's pharmaceutical industry has emerged as a formidable force on the world stage, contributing significantly to global health by produc...
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
- 2025 Outlook: Will pharma sector get a shot in its arm in 2025?Pharma 2025 Forecast: Pharma and healthcare mutual funds have topped with an average return of 38.05% in 2024. HDFC Pharma and Healthcare F...
- EU and China launch mechanism to facilitate industrial data flowsThe European Union and China have started discussions under a new system designed to streamline cross-border data flows. This initiative wi...
- Foram Parekh on what to bet on in pharma packForam Parekh shares insights on CDMO companies' positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about L...
- China says detained employee of Japan firm suspected of espionage activities"This Japanese citizen is suspected of engaging in espionage activities," Mao said, adding that China had notified the Japanese embassy in ...
- Centre may take up Trump's foreign medicines restrictions during FTA talks, downplays impactUS President Donald Trump has signed an executive order that requires Washington to develop a list of essential medicines and buy them as w...
- Mega FDI plan to focus on faster pharma approvalsThe govt has begun examining ways to shore up foreign investments, including a fast-track mechanism to clear applications of companies espe...
- NCLT rejects Sun Pharma’s plan to demerge overseas subsidiaryThe company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlan...
- Chinese growth shot’s some years away for pharma companiesFor most Indian pharmaceutical cos venturing into China, market is still restricted to licensing of speciality products & monetisation may ...
- China's new drug law may open door for Indian generic medicines: ReportNo major Indian pharma company managed to establish itself in China in view of the rigid regulations and the costs involved.
- Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovationThe recent Supreme Court judgement against Novartis has reopened old debates on drug patents, affordable healthcare and India as a destinat...
- Patients: How pharma, governments will change post-Glivec rulingThe Supreme Court’s landmark judgment on the Novartis Glivec case — disallowing a patent on minor modifications — has started a global deba...
- Pharma council seeks changes to tax laws on export creditPharma Export Promotion Council has written to ministries of commerce and finance to amend tax laws with respect to export credit.
- China beats India in race to attract global pharma companiesIn the past two years, cos such as GlaxoSmithkline, Novartis and Astra Zeneca have turned focus to China, promising investment worth billio...
- MNC pharma firms told to launch latest drugs in IndiaThe government has asked MNC pharma companies to launch latest drugs in India.
- PSU pharma cos may be kept out of price control for nowThe government is planning to exempt PSUs such as Indian Drug and Pharmaceuticals, Bengal Chemicals and Hindustan Antibiotics from the pric...
- Pharma cos say shortage loomsCostly imports of ingredients from China may take 20% drugs off shelf.
- Novartis warns India of losing R&D biz to ChinaMultinational drug makers would prefer China for investments in pharma research so long as India keeps the bar for patenting a drug so high...
Load More
